Skip to main content
SpringerLink
Log in

Baxter BioScience is undertaking a voluntary market withdrawal of its IV immune globulin product GammaGard Liquid.

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.GammaGard liquid, immune globulin intravenous (human). Internet Document: [1 page], 4 Jun 2010. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baxter BioScience is undertaking a voluntary market withdrawal of its IV immune globulin product GammaGard Liquid.. React. Wkly. 1305, 4 (2010). https://doi.org/10.2165/00128415-201013050-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013050-00006

Keywords

Search

Navigation